https://ift.tt/2IVHF6y

In past three months, Sun Pharma had outperformed the market by surging 38% as compared to a 9% rise in the benchmark index till Thursday.

from Markets https://ift.tt/2Ct9Uqr

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads